What are Edwards Lifesciences's profit margins?

Edwards Lifesciences (EW) runs a 77.9% gross margin and a 21.4% operating margin, with a 17.4% net margin.

Where do Edwards Lifesciences's ratios come from?

Every ratio is computed from Edwards Lifesciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Edwards Lifesciences EW Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	314.6%-3.8pp	318.4%-7.4pp	325.8%+8.8pp	317%+14.4pp
Operating margin	96.7%-8.5pp	105.2%-13.9pp	119.2%-9.3pp	128.4%+9.6pp
Net margin	189.6%-21.2pp	210.8%+81.6pp	129.3%+12.1pp	117.2%+10.8pp
EBITDA margin	107.4%-9.3pp	116.7%-15.4pp	132.1%-7.1pp	139.2%+10.0pp
Returns
Return on equity	119%-25.4pp	144.4%+51.9pp	92.5%-14.0pp	106.5%-5.1pp
Return on assets	90.4%-14.9pp	105.3%+40.1pp	65.2%-8.1pp	73.3%+0.8pp
Return on invested capital	65.1%-13.0pp	78.1%-2.4pp	80.5%-31.5pp	112%-9.1pp
Efficiency
Asset turnover	1.9×-0.2×	2.1×0.0×	2×-0.5×	2.5×-0.2×
Inventory turnover	4.4×+0.3×	4.2×—	——	——
Liquidity
Current ratio	16.9×+1.8×	15.1×+2.3×	12.8×-0.8×	13.6×-0.7×
Quick ratio	13.9×+2.0×	11.9×+2.3×	9.5×-0.9×	10.4×-0.6×
Cash ratio	7.9×+1.5×	6.4×+2.6×	3.8×-0.6×	4.5×-0.9×
Leverage
Debt-to-equity	0.3×-0.1×	0.3×-0.1×	0.4×0.0×	0.5×-0.1×
Debt-to-assets	0.2×0.0×	0.2×-0.1×	0.3×0.0×	0.3×0.0×
Net debt / EBITDA	-6×-1.6×	-4.4×-3.2×	-1.2×-0.4×	-0.8×+0.6×
Interest coverage	276.9×-15.5×	292.4×+2.3×	290.1×-58.4×	348.5×+11.0×
Per Share
Book value per share	$70.24+23.8%	$56.73+34.9%	$42.07+10.6%	$38.03+13.4%
Valuation
Market capitalization	$182.08B-7.4%	$196.6B+0.5%	$195.69B-14.8%	$229.62B-14.5%
Enterprise value	$172.81B-8.9%	$189.77B-2.2%	$193.95B-15.0%	$228.1B-14.3%
Price / earnings	100.3×+1.9×	98.5×-38.8×	137.2×-16.3×	153.6×-53.6×
Price / sales	31.4×-6.0×	37.4×-6.9×	44.3×-0.3×	44.6×-9.6×
Price / book	17.7×-6.4×	24.1×-6.5×	30.6×-8.0×	38.6×-11.8×
EV / EBITDA	112.1×-11.7×	123.8×-9.2×	133×+5.7×	127.3×-41.8×
EV / sales	29.8×-6.3×	36.1×-7.8×	43.9×-0.4×	44.3×-9.4×
Earnings yield	24.3%-0.8pp	25.1%+13.3pp	11.8%+1.1pp	10.7%+2.9pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Edwards Lifesciences.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Edwards Lifesciences's profit margins?: Edwards Lifesciences (EW) runs a 77.9% gross margin and a 21.4% operating margin, with a 17.4% net margin.
Where do Edwards Lifesciences's ratios come from?: Every ratio is computed from Edwards Lifesciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.